53 hedge funds and large institutions have $7.63M invested in iBio in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

56% less capital invested

Capital invested by funds: $17.5M → $7.63M (-$9.87M)

59% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 27

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$154K
Puts
$121K
Net Calls
Net Calls Change

Top Buyers

1 +$1.22M
2 +$480K
3 +$272K
4
Renaissance Technologies
Renaissance Technologies
New York
+$189K
5
Citadel Advisors
Citadel Advisors
Florida
+$131K

Top Sellers

1 -$2.97M
2 -$982K
3 -$417K
4
Northern Trust
Northern Trust
Illinois
-$373K
5
Nuveen Asset Management
Nuveen Asset Management
Illinois
-$360K
Name Holding Trade Value Shares
Change
Change in
Stake
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73